Paediatric craniopharyngioma: A pathological review

Journal of Pediatric Endocrinology and Metabolism

Volumn 19, Issue SUPPL. 1, 2006, Pages 295-298

  Nozza, Paolo ^a   Gambini, Claudio ^a  

^a G GASLINI INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM SALT; CYCLIN A; CYTOKERATIN 13; CYTOKERATIN 14; CYTOKERATIN 18; CYTOKERATIN 19; CYTOKERATIN 7; CYTOKERATIN 8; EPITHELIAL MEMBRANE ANTIGEN; KI 67 ANTIGEN; WNT PROTEIN;

AMELOBLASTOMA; CALCINOSIS; CHILDHOOD CANCER; CORRELATION ANALYSIS; CRANIOPHARYNGIOMA; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; EPITHELIUM TUMOR; GIANT CELL; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATORY CELL; MACROPHAGE; ODONTOGENIC CYST; ODONTOGENIC TUMOR; OSSIFICATION; PATHOGENESIS; PROGNOSIS; PROTEIN EXPRESSION; RECURRENCE RISK; REVIEW; SELLA TURCICA TUMOR; T LYMPHOCYTE; TISSUE NECROSIS; TUMOR RECURRENCE; TUMOR VOLUME;

CHILD; CRANIOPHARYNGIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; PITUITARY GLAND; PITUITARY NEOPLASMS;

EID: 33646205270     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Burger PC, Scheithauer BW. Tumors of the Central Nervous System. Atlas of Tumor Pathology, 3rd Series. Fascicle 10. Washington, DC: AFIP, 1994; 349-354.
2. Janzer RC, Burger PC, Giangaspero F, Paulus W. Craniopharyngioma. In: Kleihues P, Cavanee WK, eds. Tumors of the Nervous System. Lyon: IARC Press, 2000; 244-248.
3. Thapar K, Kovacs K. Neoplasms of the sellar region. In: Bigner DD, McLendon RE, Bruner JM, eds. Russell and Rubinstein's Pathology of Tumors of the Nervous System, 6th Ed. New York, NY: Oxford University Press, 1998; 629-640.
4. Giangaspero F, Burger PC, Osborne DR, Stein RB. Suprasellar papillary squamous epithelioma ("papillary craniopharyngioma"). Am J Surg Pathol 1984; 8: 57-64.
5. Weiner HL, Wisoff JH, Rosenberg ME, Kupersmith MJ, Cohen H, Zagzag D, Shiminski-Maher T, Flamm ES, Epstein FJ, Miller DC. Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome. Neurosurgery 1994; 35: 1001-1010.
6. Ishii K, Sugita K, Kobayashi H, Kamida T, Fujiki M, Izumi T, Mori T. Intracranial ectopic recurrence of craniopharyngioma after Ommaya reservoir implantation. Pediatr Neurosurg 2004; 40: 230-233.
7. Kawamata T, Kubo O, Kamikawa S, Hori T. Ectopic clival craniopharyngioma. Acta Neurochir (Wien) 2002; 144: 1221-1224.
8. Novegno F, Di Rocco F, Colosimo C Jr, Lauriola L, Caldarelli M. Ectopic recurrences of craniopharyngioma. Childs Nerv Syst 2002; 18: 468-473.
9. Karavitaki, Brufani C, Warner JT, Adams CBT, Richards P, Ansorge O, Shine B, Turner HE, Wass JAH. Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up. Clin Endocrinol 2005; 62: 397-409.
10. Gupta K, Kuhn MJ, Shevlin DW, Wacaser LE. Metastatic craniopharyngioma. AJNR 1999; 20: 1059-1060.
11. Kristopaitis T, Thomas C, Petruzzelli GJ, Lee JM. Malignant craniopharyngioma. Arch Pathol Lab Med 2000; 124: 1356-1360.
12. Virik K, Turner J, Garrick R, Sheehy JP. Malignant transformation of craniopharyngioma. J Clin Neurosci 1999; 6: 27-30.
13. Kurosaki M, Saeger W, Ludecke DK. Immunohistochemical localisation of cytokeratins in craniopharyngioma. Acta Neurochir (Wien) 2001; 143: 147-151.
14. Tateyama H, Tada T, Okabe M, Takahashi E, Eimoto T. Different keratin profiles in craniopharyngioma subtypes and ameloblastomas. Pathol Res Pract 2001; 197: 735-742.
15. Xin W, Rubin MA, McKeever PE. Differential expression of cytokeratins 8 and 20 distinguishes craniopharyngioma from Rathke cleft cyst. Arch Pathol Lab Med 2002; 126: 1174-1178.
16. Bernstein ML, Buchino JJ. The histologic similarity between craniopharyngioma and odontogenic lesions: a reappraisal. Oral Surg Oral Med Oral Pathol 1983; 56: 502-511.
17. Paulus W, Stockel C, Krauss J, Sorensen N, Roggendorf W. Odontogenic classification of craniopharyngiomas: a clinicopathological study of 54 cases. Histopathology 1997; 30: 172-176.
18. Nishi T, Kuratsu J, Takeshima H, Saito Y, Kochi M, Ushio Y. Prognostic significance of the MIB-1 labeling index for patient with craniopharyngioma. Int J Mol Med 1999; 3: 157-161.
19. Duò D, Gasverde S, Benech F, Zenga F, Giordana MT. MIB-1 immunoreactivity in craniopharyngiomas: a clinico-pathological analysis. Clin Neuropathol 2003; 22: 229-234.
20. Losa M, Vimercati A, Acerno S, Barzaghi RL, Mortini P, Mangili F, Terreni MR, Santambrogio G, Giovanelli M. Correlation between clinical characteristics and proliferative activity in patients with craniopharyngioma. J Neurol Neurosurg Psychiatry 2004; 75: 889-892.
21. Vidal S, Kovacs K, Lloyd RV, Meyer FB, Scheithauer BW. Angiogenesis in patients with craniopharyngiomas. Correlation with treatment and outcome. Cancer 2002; 94: 738-745.
22. Rienstein S, Adams EF, Pilzer D, Goldring AA, Goldman B, Friedman E. Comparative genomic hybridization analysis of craniopharyngiomas. J Neurosurg 2003; 98: 162-164.
23. Rickert CH, Paulus W. Lack of chromosomal imbalances in adamantinomatous and papillary craniopharyngiomas. J Neurol Neurosurg Psychiatry 2003; 74: 260-261.
24. Nozaki M, Tada M, Matsumoto R, Sawamura Y, Abe H, Iggo RD. Rare occurrence of inactivating p53 gene mutations in primary non-astrocytic tumors of the central nervous system: reappraisal by yeast functional assay. Acta Neuropathol 1998; 95: 291-296.
25. Kato K, Nakatani Y, Kanno H, Inayama Y, Ijiri R, Nagahara N, Miyake T, Tanaka M, Ito Y, Aida N, Tachibana K, Sekido K, Tanaka Y. Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma. J Pathol 2004; 203: 814-821.